Hosts: Vincent Racaniello, Alan Dove, and LJ Tan On Episode 103 of the podcast This Week in Virology, Vincent and Alan discuss influenza vaccines with LJ Tan of the American Medical Association. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV103.mp3″] Click the arrow above to play, or right-click to download TWiV #103 (56 MB .mp3, 77 minutes) Subscribe to TWiV (free) in …
Host: Vincent Racaniello Vincent tours the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, speaking with exhibitors and visitors, including Professors Derek Smith, Michael Schmidt, Frederick Hayden, and Myra McClure. Many thanks to Chris Condayan and Ray Ortega of the American Society for Microbiology for recording and editing this episode. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV099.mp3″] Click …
Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, and Rich Condit On episode #95 of the podcast This Week in Virology, Vincent, Dickson, Alan, and Rich consider the end of the influenza H1N1 pandemic, dengue in Florida, vaccinia virus infection in Brazilian monkeys, and viruses in the faecal microbiota. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV095.mp3″] Click the arrow above to play, or …
The World Health Organization has declared the end of the pandemic caused by H1N1 influenza virus. According to Director-General Margaret Chan, The world is no longer in phase 6 of influenza pandemic alert. We are now moving into the post-pandemic period. The new H1N1 virus has largely run its course. As we enter the post-pandemic …
Hosts: Vincent Racaniello and Alan Dove On episode #89 of the podcast This Week in Virology, Vincent and Alan review recent findings on the association of the retrovirus XMRV with ME/CFS, reassortment of 2009 pandemic H1N1 influenza virus in swine, and where influenza viruses travel in the off-season. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV089.mp3″] Click the arrow above to play, …
A serious shortcoming of current influenza virus vaccines is the need to reformulate them every year or two as the virus undergoes antigenic drift. Many virologists have been captivated by the idea of a more universal vaccine that would endure longer, perhaps a decade or more. The identification of a conserved domain in the stalk …
